marrow that, when cultured with appropriate conditioned media, megakaryocyte, erythroid, and phagocytic cells. Such a cell, give rise to colonies of either granulocytes or macrophages, or a although still capable of self-renewal, is destined to differentiate combination of both. These progenitors have a limited capacity still further to form progenitors, with bi-or unilineage potential. for self-renewal. Till and McCullough (1) showed that a bone We do not know whether there are any exogenous forces that marrow transplant given to an irradiated mouse would give rise drive these early steps of differentiation. Growth factors are to separate colonies of hematopoietic cells in the spleen of the certainly necessary to accomplish the differentiation of the recipient. Each colony was derived from a single cell, and many lineage-committed progenitors of the blood cell precursors, but of the colonies contained cells equally capable of such colony Ogawa (1 3) has convincingly shown that the decision to become formation when transplanted into a second irradiated mouse. responsive to a particular lineage-specific growth factor (and Such cells, endowed with the capacity for unlimited self-renewal, presumably to express its receptor) appears to be entirely random. may be referred to properly as stem cells. Alpen and Cranmore The event probably depends on the timing of expression of one (4) demonstrated that increased red cell production in response or more lineage-specific DNA binding proteins. Such a switching to bleeding is not dependent on an increased mitotic rate of protein that binds to a human globin promoter has recently been existing erythroid precursors. Instead, it results from differentia-identified and cloned by Tsai et al. (14) . Interestingly, this protein tion of erythroid progenitor cells into a newly formed population may be detected in megakaryocytes as well as erythroid cells of erythroblasts. Finally, Axelrad et al. described the committed (14a), providing convincing evidence that these cells share a erythroid progenitor cell in vitro (5). common progenitor. In any case, when progenitor cells differIn this discussion, we will focus on the nature of the progenitors entiate to a single-lineage state, they virtually lose their capacity and the interaction of growth factors with them. A more complete for self-renewal because all of the daughter cells will eventually review of the growth factors themselves is beyond the scope of differentiate to a precursor cell. this presentation.
The hematopoietic growth factors that drive the differentiation of progenitors include IL-3, granulocyte-macrophage-colony-PROGENITORS stimulating factor (GM-CSF), granulocyte (G)-CSF, macrophage (M)-CSF, IL-4, IL-5, IL-6, and erythropoietin (1 5-1 8). They act Progenitor cells can be purified from a marrow, blood, or fetal in combination to induce the terminal differentiation of lineageliver population by depletion of most of the precursor cells using specific progenitors. a mixture of lineage-specific MAb (6, 7). The antibody-coated cells may then be removed by one or more physical techniques, leaving behind a population of enriched progenitors that may ERYTHROPOIESIS now comprise UP to about 10% of the cell population. These can Erythropoietin, the growth factor responsible for the regulation be further purified by MAb that bind to remaining progenitors. of erythropoiesis, has been known since the observations of Antibodies reactive with human class 11 histocompatibility anti-Carnot and Deflandre (19) . Its amino acid sequence was detergens (6), CD34 @), and an antibody called RFBl (9), can be mined by biochemical techniques advanced by Goldwasser et al.
used in this second positive selection step. Anti-Thy-1 can be (20) , and from those data the erythropoietin gene was cloned similarly used in mice (10). Depending on the initial source of (21) . The glycosylated mol wt is 34-39 kD. The gene is located hematopoletlc tlssue, the progenitors may be concentrated to up on chromosome 7 (22 (28) . Interestingly, most fetal BFU-E respond to ment of the receptor is now under study, and its role in the erythropoietin alone. They do not require an additional source pathogenesis of certain refractory anemias, such as the Diamond of BPA. In that sense, they resemble adult CFU-E (33). In Blackfan anemia, is currently being examined. addition, fetal erythroid progenitors, as well as the progenitors Figure 2 summarizes the effects of erythropoietin and other or erythrocytes in polycythemia Vera, require lower concentragrowth factors on erythropoiesis in vivo and in vitro. The im-tions of erythropoietin to induce them to form erythroid cell mature myeloid stem cell randomly differentiates to an immature colonies in vitro (33, 34) . erythroid progenitor known as erythroid burst forming unit Erythropoietin has been successfully administered in the ane-(BFU-E), so called because individual BFU-E in vitro give rise to mia of chronic renal failure, where it has been shown to decrease a large multisegmented colony (5). After exposure to a combi-and even eliminate transfusion requirements (35) . It is now under nation of erythropoietin and either IL-3 or GM-CSF, BFU-E study in a number of chronic anemias, and may prove to be divide and migrate in culture for several days. Then each daugh-extremely useful in many of them, particularly in the anemia of ter cell begins to form large colonies of differentiated erythro-prematurity. Its role in the various bone marrow failure synblasts shown as solid circles in an inset on the middle left side of dromes is uncertain because the level of erythropoietin is quite Figure 2 . In normal individuals, BFU-E rarely give rise to eryth-high in those conditions. roblasts in vivo; instead, they divide and mature to form erythroid colony-forming units (CFU-E) (27) . These progenitors are considerably more numerous in the marrow than are BFU-E. In PHAGOCYTOPOIESIS vitro, most CFU-E respond to erythropoietin alone by forming
The phagocyte progenitor system and its interaction with single, relatively small colonies of 60 and 120 cells as shown in growth factors is considerably more complex and involves IL-5, the insert on the middle right side of the figure. In response to M-CSF, and G-CSF in addition to IL-3 and GM-CSF. This is erythropoietin in vivo, they replicate and also form proerythrob-illustrated in Figure 3 . The differentiation of phagocyte progenlasts, which in turn form colonies of approximately eight to 16 itors is illustrated in Figure 3 from left to right. The colonies to reticulocytes when they are induced with erythropoietin. Thus, which each progenitor gives rise in vitro are shown in the rectanstress erythropoiesis demands rapid progenitor-derived erythro-gular boxes and the factors required to produce each colony in blast production and CFU-E replication. The requirement of vitro are noted next to an arrow drawn from the progenitor to most adult BFU-E and a minority of CFU-E for a multilineage the colony. uniquely restricted to eosinophil formation (CFU-EO). The terminal differentiation of that progenitor in vitro produces an eosinophil colony shown in an insert at the top left. Production of such colonies of eosinophils in vitro requires the presence of IL-5 in concert with either IL-3 or GM-CSF. These are shown next to the arrow from CFU-EO to the colony. IL-5 is a 45 000-kD glycoprotein located in a growth factor-rich region of chromosome 5q 27-31 (36) . It is expressed almost exclusively in T cells, as predicted from the classic work of Baston and Beeson (37) more than 20 years ago.
The multilineage progenitor may also differentiate to a bilineage progenitor of colony-forming units (CFU)-GM. When this cell is stimulated in vitro with either IL-3 or GM-CSF and a source of two single-lineage growth factors, G-CSF and M-CSF, respectively, it forms typical mixed colonies of granulocytes Figure 4 shows an immature blast cell at the top differentiating to monocytes, neutrophils, and eosinophils. The presence of GM-CSF, M-CSF, and IL-3 receptors are indicated by the abbreviation for the hormone followed by the letter R. When GM-CSF and IL-3 encounter their receptors on mature cells, they both induce a family of adhesive proteins on the surfaces of monocytes and presumably on eosinophils, and GM-CSF has a similar effect on neutrophils (42, 43) . In a similar manner, both factors enhance antibody-dependent cytotoxicity (ADCC), superoxide production, and phagocytosis (44, 45) in the cells that bear their receptors; thus, they play an important role in the function as well as the production of phagocytic cells.
REGULATION OF IL-3
The cellular source of IL-3 in blood is unique. Niemeyer et al. (46) (Fig. 5 ) demonstrated by Northern analysis that IL-3 mRNA, shown in an MLA 144 T cell line extract on the left, is found in the B cell-depleted T and NK cells of a mononuclear population, and in a T cell clone on the right. But the fraction of activated T cells that express the gene is extremely small. This is revealed in Figure 6 , taken from the studies of Wimperis et al. (47) , who have used in situ hybridization to measure GM-CSF and IL-3-specific mRNA in individual mononuclear cells. The upper panels show that less than 10% of Ca++ ionophore and phorbol myristate acetate activated cells express GM-CSF (the right-hand panel is a dark field view of the left-hand panel) and the lower panels show that less than 1 % express IL-3. A marked increase in both the number of grains per cell and percentage of expressing cells is induced by 24-h treatment of the cells with IL-2 prior to exposure to Ca++ ionophore/phorbol myristate acetate (data not shown). In a recent publication (48) , it is reported that murine IL-3 is heavily expressed in hippocampal cells. Its possible function in neural cells will be a subject of investigations of the future.
Recently, Mathey-Prevot et al. have provided some important data on the regulation of IL-3 (49). In brief, Mathey-Prevot has constructed a reporter IL-3 gene by inserting a 12-mer in its first exon. The expression of this reporter can be readily detected and distinguished from the endogenous gene by an RNAase protection assay. The reporter gene, attached to whatever regulatory elements one wishes to study, is then inserted by transfection into the MLA 144 gibbon T cell leukemia line, which is known to express high levels of IL-3 when stimulated with phorbol esters. Mathey-Prevot has cloned and sequenced the 617 base pairs 5' to the cap site of the IL-3 gene (Fig. 7) , and he and Andrews have studied that fragment in two general ways. First, they have searched for nuclear proteins that may bind to specific areas of this segment with particular emphasis on proteins that may be induced by phorbol ester. Their methods include standard gel shift, footprint, and methylation interference assays. Second, they have incorporated pieces of this fragment as promoter elements in their reporter gene experiments. Three sites are of particular interest. These are, from left to right, the presence of an AP-1 site to which the product of the jun oncogene is known to bind. The presence of this AP-1 site is essential for maximum expression of the transfected reporter gene. The site 3' to the AP-1, now called NIP, was detected by Andrews' protein binding experiments. Recent studies by Mathey-Prevot (49) suggest that this site suppresses IL-3 production. Finally, there are the two cytokine (CK) sites near the tata that are commonly found to be involved in the expression of several lymphokines, particularly GM-CSF. These are potential positive regulators of IL-3, but more data are needed to dissect their role and that of neighboring motifs more carefully.
Thus, in summary, three sites 5' to the tata box regulate the expression of the IL-3 gene. Two, the AP-1 site and the region in or around the CK sites, are likely positive regulators, whereas the NIP site is a negative regulator. Understanding of the proteins that interact with these sites and the inducers of their synthesis will certainly occupy the attention of students of hematopoietic growth factor function.
Review of Figure 1 provides a summary of the points that we have tried to make so far. Again, we see the pluri-and multipotential stem cells randomly multiplying and adopting lineage specificity to become progenitors of the morphologically identified precursors. Note that IL-3 and IL-6 appear to play a role in the self-renewal of the myloid stem cell, and that a combination of growth factors, including a multipotential growth factor such as IL-3 or GM-CSF with a unilineage growth factor, be it IL-5 for eosinophils, erythropoietin for erythroid cells, G-CSF for granulocytes, or M-CSF for monocytes, is generally the rule. IL-4 and IL-6 can further potentiate the effects of these combinations, at least in murine systems (50, 51) . With increasing maturity of the single-lineage progenitors, the single-lineage growth factors can operate independently. An important additional point is that the single-lineage growth factors induce not only differentiation of mature progenitors but their replication as well. This provides capacity for rapid expansion of the committed progenitor pool during periods of hematopoietic demand. The bottom of Figure 1 adds a further level of regulation put forward by several studies (52) (53) (54) (55) . Monocytes, T cells, and stromal cells play an important role in the production of hematopoietic factors. Activated monocytes release IL-1 and TNF. Both of these factors stimulate stromal endothelial cells and fibroblasts to release GM-CSF and G-CSF. M-CSF is synthesized constitutively; thus, monocyte-activated stroma provides an important source of growth factor production. T cells embedded in stroma also play an important role because activated T cells are the sole source of IL-3 and IL-5; they also produce GM-CSF.
CLINICAL APPLICATIONS
Both GM-CSF and G-CSF have been explored in clinical trials. The latter is particularly useful in congenital and chemotherapyinduced neutropenia (56) (57) (58) and may be less toxic in high doses than is GM-CSF.
GM-CSF was examined first in a simian system by Donahue et al. (59) with the results shown in Figure 8 . The upper righthand panel shows a marked increase in phagocyte production that accompanied a 7-d infusion of GM-CSF to a normal animal. The upper left-hand panel shows the results of GM-CSF treatment of a simian with a type D retrovirus infection and severe pancytopenia and marrow hypercellularity very similar to that observed in AIDS. Again, there is a prompt granulocyte response, and a reticulocyte response as well, shown on the lower left. Erythropoietin levels were elevated in this ill animal.
The first studies of GM-CSF in humans were conducted by Groopman et al. (60) , who showed that the drug also stimulates granulocyte production in these retrovirus-infected individuals. Nienhuis et al. (61) showed that pre-and posttreatment with GM-CSF, either pre-or postirradiation, enhanced rapid recovery of neutrophil counts in a simian autotransplant model. This was also observed in a human autotransplant system by Brandt et a/. (62) . Since then, GM-CSF has been studied by several workers in a wide variety of marrow failure syndromes with variable results (63, 64) . The recent evaluations of recombinant GM-CSF treatment of severe aplastic anemia of childhood by Guinan et al. (65) are of particular interest. Of eight children studied to date, six had granulocyte responses into the protective range. One had a trilineage response as well (Fig. 9) . One patient could not complete the course of treatment due to an allergic response and another failed to respond.
We must emphasize, however, that the synergistic interactions of growth factors with progenitors suggest that single agents are not likely to be as useful as combinations. Sieff et al. (38) have already shown that IL-3 and GM-CSF act synergistically in vitro. That has been observed as well by Donahue et al. (66) in vivo (Fig. 10) . Here we see on the upper panel that a standard dose of IL-3 given for seven d has little or no effect on granulocytopoiesis on the simian system in vivo. The middle panel shows that a small dose of GM-CSF given from d 7 to 14 has little effect as well. But when the two are combined, as shown on the bottom panel, a very large response occurs. Presumably IL-3 induces the replication of progenitors, and the later addition of GM-CSF together with ambient G-CSF, M-CSF, and erythropoietin induces their terminal differentation. 
